Differential release of cholecystokinin by morphine in rat spinal cord

Neuroscience Letters

Volumn 245, Issue 1, 1998, Pages 13-16

  De Araujo Lucas, Guilherme ^a   Alster, Pawel ^a   Brodin, Ernst ^b   Wiesenfeld Hallin, Zsuzsanna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Div Clin Pharmacol Karolinska I   (Sweden)

Author keywords

Axotomy; Cholecystokinin; Inflammation; Microdialysis; Morphine; Spinal cord

Indexed keywords

CHOLECYSTOKININ; MORPHINE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; EXTRACELLULAR SPACE; LUMBAR SPINAL CORD; MALE; MICRODIALYSIS; NERVE FIBER TRANSECTION; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANALGESICS, OPIOID; ANIMALS; AXOTOMY; CHOLECYSTOKININ; EXTRACELLULAR SPACE; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MALE; MICRODIALYSIS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0032571156     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00163-3     Document Type: Article

References (23)

1. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Benoliel J.J., Collin E., Mauborgne A., Bourgoin S., Legrand J.C., Hamon M., Cesselin F. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material. Brain Res. 653:1994;81-91.
3. Baber N.S., Dourish C.T., Hill D.R. The role of CCK, caerulein, and CCK antagonists in nociception. Pain. 39:1989;307-328.
4. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
5. Dickenson A., Sullivan A.F. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn. Pain. 24:1986;211-222.
6. Dickenson, A.H., Where and how do opioids act? In G.F. Gebhart, D.L. Hammond and T.S. Jensen (Eds.), Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, Vol. 2, IASP Press, Seattle, WA, 1994, pp. 525-551.
7. Dourish C.T., O'Neill M.F., Coughlan L., Kitchener S.J., Hawley D., Iversen S.D. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 176:1990;35-44.
8. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
9. Fuxe K., Agnati L.F. Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses. Med. Res. Rev. 5:1985;441-482.
10. Han J.S., Ren M.F., Fan S.G., Wang X.J. Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors. Life Sci. 45:1989;117-123.
11. Hökfelt, T., Zhang, X., Xu, Z.-Q., Rong, J.-R., Shi, T., Corness, J., Kerekes, N., Landry, M., Rydh-Rinder, M., Broberger, C., Wiesenfeld-Hallin, Z., Bartfai, T., Elde, R. and Ju, G., Cellular and synaptic mechanisms in transmission of pain from acute to chronic. In T.S. Jensen, J.A. Turner and Z. Wiesenfeld-Hallin (Eds.), Proceedings of the 8th World Congress on Pain, Progress in Pain Research and Management, Vol. 8, IASP Press, Seattle, WA, 1997, pp. 133-153.
12. Ju G., Hökfelt T., Fischer J.A., Frey P., Rehfeld J.F., Dockray G.J. Does cholecystokinin-like immunoreactivity in rat primary sensory neurons represent calcitonin gene-related peptide? Neurosci. Lett. 68:1986;305-310.
13. Kayser V., Guilbaud G. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats. Brain Res. 267:1983;131-138.
14. Stanfa L.C., Dickenson A.H. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenan inflammation. Br. J. Pharmacol. 108:1993;967-973.
15. Stanfa L., Sullivan A.F., Dickenson A. Alterations in neuronal excitability and potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation. Pain. 50:1992;345-354.
16. Wang X.J., Han J.S. Modification by cholecystokinin octapeptide of the binding of mu, delta and kappa opioid receptors. J. Neurochem. 55:1990;1379-1382.
17. Watkins L.R., Kinscheck I.B., Mayer D.J. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science. 224:1984;395-396.
18. Wiesenfeld-Hallin Z., Xu X.-J., Hughes J., Horwell D.C., Hökfelt T. PD 134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc. Natl. Acad. Sci. USA. 87:1990;7105-7109.
19. Wiesenfeld-Hallin Z., Xu X.-J. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance. Regul. Peptides. 65:1996;23-28.
20. Xu X.-J., Puke M.J.C., Verge V.M.K., Wiesenfeld-Hallin Z., Hughes J., Hökfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci. Lett. 152:1993;129-132.
21. You Z.B., Herrera-Marschitz M., Brodin E., Meana J.J., Morini P., Hökfelt T., Silveira R., Goiny M., Ungerstedt U. On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. J. Neurochem. 62:1994;76-85.
22. Zhang X., Dagerlind Å., Elde R.P., Castel M.-N., Broberger C., Wiesenfeld-Hallin Z., Hökfelt T. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy. Neuroscience. 57:1993;227-233.
23. Zhou Y., Sun Y.H., Zhang Z.W., Han J.S. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord. Eur. J. Pharmacol. 234:1993;147-154.